Easing the pain of partnerships: How can we make cross-sector collaborations in R&D worth the effort?
Everyone knows that to get a discovery from bench to bedside, no one can go it alone. In today’s biomedical R&D, all stakeholders have to work with other sectors to achieve their goals. Even if they don’t want to. And even if it’s hard (and it’s likely hard).
The players come to collaborations with varied goals, cultures, and stakeholders they have to report to (from shareholders to patients). How can you deal with the pressure to have a single collaboration serve many masters? How do you get to a win-win across stakeholders? How can you minimize the pain of collaboration?
- Jodi Black, Deputy Director, Office of Extramural Research, National Institutes of Health
- Todd Sherer, CEO, The Michael J. Fox Foundation for Parkinson’s Research
- Stephen Yates, Clinical Program Director, UCB Biosciences, Inc.
- Luke Timmerman, Editor, Timmerman Report; Author, "Hood: Trailblazer of the Genomics Age" (moderator)